A 0 1 0 1 O
confirmed 2 11 2 11 O
history 12 19 12 19 O
of 20 22 20 22 O
encephalitis 23 35 23 35 B-chronic_disease
, 35 36 35 36 O
meningitis 37 47 37 47 B-chronic_disease
, 47 48 47 48 O
or 49 51 49 51 O
uncontrolled 52 64 52 64 O
seizures 65 73 65 73 B-chronic_disease
in 74 76 74 76 O
the 77 80 77 80 O
year 81 85 81 85 O
prior 86 91 86 91 O
to 92 94 92 94 O
informed 95 103 95 103 O
consent 104 111 104 111 O

A 0 1 112 113 O
known 2 7 114 119 O
or 8 10 120 122 O
underlying 11 21 123 133 O
medical 22 29 134 141 O
condition 30 39 142 151 O
that 40 44 152 156 O
, 44 45 156 157 O
in 46 48 158 160 O
the 49 52 161 164 O
opinion 53 60 165 172 O
of 61 63 173 175 O
the 64 67 176 179 O
Investigator 68 80 180 192 O
, 80 81 192 193 O
could 82 87 194 199 O
make 88 92 200 204 O
the 93 96 205 208 O
administration 97 111 209 223 O
of 112 114 224 226 O
the 115 118 227 230 O
study 119 124 231 236 B-treatment
drug 125 129 237 241 I-treatment
hazardous 130 139 242 251 O
to 140 142 252 254 O
the 143 146 255 258 O
subject 147 154 259 266 O
or 155 157 267 269 O
could 158 163 270 275 O
adversely 164 173 276 285 O
affect 174 180 286 292 O
the 181 184 293 296 O
ability 185 192 297 304 O
of 193 195 305 307 O
the 196 199 308 311 O
subject 200 207 312 319 O
to 208 210 320 322 O
comply 211 217 323 329 O
with 218 222 330 334 O
or 223 225 335 337 O
tolerate 226 234 338 346 O
the 235 238 347 350 O
study 239 244 351 356 O

A 0 1 357 358 O
woman 2 7 359 364 B-gender
of 8 10 365 367 O
childbearing 11 23 368 380 O
potential 24 33 381 390 O
( 34 35 391 392 O
WOCBP 35 40 392 397 O
) 40 41 397 398 O
agrees 42 48 399 405 B-contraception_consent
to 49 51 406 408 I-contraception_consent
use 52 55 409 412 I-contraception_consent
method(s 56 64 413 421 I-contraception_consent
) 64 65 421 422 I-contraception_consent
of 66 68 423 425 I-contraception_consent
contraception 69 82 426 439 I-contraception_consent

Absolute 0 8 440 448 B-clinical_variable
neutrophil 9 19 449 459 I-clinical_variable
count 20 25 460 465 I-clinical_variable
( 26 27 466 467 I-clinical_variable
ANC 27 30 467 470 I-clinical_variable
) 30 31 470 471 I-clinical_variable
> 32 33 472 473 O
= 33 34 473 474 O
1.5 35 38 475 478 B-lower_bound
X 39 40 479 480 I-lower_bound
10 41 43 481 483 I-lower_bound
^ 43 44 483 484 I-lower_bound
9 44 45 484 485 I-lower_bound
/ 45 46 485 486 I-lower_bound
L 46 47 486 487 I-lower_bound
( 48 49 488 489 O
within 49 55 489 495 O
28 56 58 496 498 B-upper_bound
days 59 63 499 503 I-upper_bound
of 64 66 504 506 O
first 67 72 507 512 B-treatment
study 73 78 513 518 I-treatment
treatment 79 88 519 528 I-treatment
) 88 89 528 529 O

Albumin 0 7 530 537 B-clinical_variable
> 8 9 538 539 O
= 9 10 539 540 O
2.5 11 14 541 544 B-lower_bound
g 15 16 545 546 I-lower_bound
/ 16 17 546 547 I-lower_bound
dL 17 19 547 549 I-lower_bound
( 20 21 550 551 O
within 21 27 551 557 O
28 28 30 558 560 B-upper_bound
days 31 35 561 565 I-upper_bound
of 36 38 566 568 O
first 39 44 569 574 O
study 45 50 575 580 O
treatment 51 60 581 590 B-treatment
) 60 61 590 591 O

All 0 3 592 595 B-gender
patients 4 12 596 604 I-gender
must 13 17 605 609 O
undergo 18 25 610 617 O
a 26 27 618 619 O
baseline 28 36 620 628 O
tumor 37 42 629 634 B-treatment
biopsy 43 49 635 641 I-treatment
; 49 50 641 642 O
in 51 53 643 645 O
Arms 54 58 646 650 O
A 59 60 651 652 O
and 61 64 653 656 O
B 65 66 657 658 O
, 66 67 658 659 O
tumor 68 73 660 665 O
biopsy 74 80 666 672 O
for 81 84 673 676 O
PD 85 87 677 679 O
- 87 88 679 680 O
L1 88 90 680 682 O
testing 91 98 683 690 O
( 99 100 691 692 O
PD 100 102 692 694 O
- 102 103 694 695 O
L1 103 105 695 697 O
positivity 106 116 698 708 O
is 117 119 709 711 O
determined 120 130 712 722 O
by 131 133 723 725 O
greater 134 141 726 733 O
than 142 146 734 738 O
or 147 149 739 741 O
equal 150 155 742 747 O
to 156 158 748 750 O
1 159 160 751 752 B-lower_bound
% 160 161 752 753 I-lower_bound
of 162 164 754 756 O
cells 165 170 757 762 O
staining 171 179 763 771 O
in 180 182 772 774 O
the 183 186 775 778 O
membrane 187 195 779 787 O
by 196 198 788 790 O
immunohistochemistry 199 219 791 811 B-treatment
) 219 220 811 812 O
is 221 223 813 815 O
required 224 232 816 824 O
for 233 236 825 828 O
stratificatio 237 250 829 842 O

Amylase 0 7 843 850 B-clinical_variable
< 8 9 851 852 O
1.5 10 13 853 856 B-upper_bound
X 14 15 857 858 I-upper_bound
ULN 16 19 859 862 I-upper_bound
( 20 21 863 864 O
within 21 27 864 870 O
28 28 30 871 873 B-upper_bound
days 31 35 874 878 I-upper_bound
of 36 38 879 881 O
first 39 44 882 887 O
study 45 50 888 893 O
treatment 51 60 894 903 B-treatment
) 60 61 903 904 O

Any 0 3 905 908 O
history 4 11 909 916 O
of 12 14 917 919 O
clinically 15 25 920 930 O
significant 26 37 931 942 O
arrhythmias 38 49 943 954 B-chronic_disease
( 50 51 955 956 O
such 51 55 956 960 O
as 56 58 961 963 O
ventricular 59 70 964 975 B-chronic_disease
tachycardia 71 82 976 987 I-chronic_disease
, 82 83 987 988 O
ventricular 84 95 989 1000 B-chronic_disease
fibrillation 96 108 1001 1013 I-chronic_disease
, 108 109 1013 1014 O
or 110 112 1015 1017 O
torsades 113 121 1018 1026 B-chronic_disease
de 122 124 1027 1029 I-chronic_disease
pointes 125 132 1030 1037 I-chronic_disease
) 132 133 1037 1038 O

Any 0 3 1039 1042 O
investigational 4 19 1043 1058 B-treatment
cytotoxic 20 29 1059 1068 I-treatment
drug 30 34 1069 1073 I-treatment
; 34 35 1073 1074 O
exposure 36 44 1075 1083 O
to 45 47 1084 1086 O
any 48 51 1087 1090 O
non 52 55 1091 1094 B-treatment
- 55 56 1094 1095 I-treatment
cytotoxic 56 65 1095 1104 I-treatment
drug 66 70 1105 1109 I-treatment
within 71 77 1110 1116 O
4 78 79 1117 1118 B-upper_bound
weeks 80 85 1119 1124 I-upper_bound
or 86 88 1125 1127 O
5 89 90 1128 1129 B-upper_bound
half 91 95 1130 1134 I-upper_bound
- 95 96 1134 1135 I-upper_bound
lives 96 101 1135 1140 I-upper_bound
( 102 103 1141 1142 O
whichever 103 112 1142 1151 O
is 113 115 1152 1154 O
shorter 116 123 1155 1162 O
) 123 124 1162 1163 O
is 125 127 1164 1166 O
prohibited 128 138 1167 1177 O

Any 0 3 1178 1181 O
major 4 9 1182 1187 B-treatment
surgery 10 17 1188 1195 I-treatment
within 18 24 1196 1202 O
the 25 28 1203 1206 O
last 29 33 1207 1211 B-upper_bound
3 34 35 1212 1213 I-upper_bound
weeks 36 41 1214 1219 I-upper_bound

Any 0 3 1220 1223 O
of 4 6 1224 1226 O
the 7 10 1227 1230 O
following 11 20 1231 1240 O
procedures 21 31 1241 1251 O
or 32 34 1252 1254 O
medications 35 46 1255 1266 B-treatment

Any 0 3 1267 1270 O
positive 4 12 1271 1279 O
test 13 17 1280 1284 O
result 18 24 1285 1291 O
for 25 28 1292 1295 O
hepatitis 29 38 1296 1305 B-chronic_disease
B 39 40 1306 1307 I-chronic_disease
or 41 43 1308 1310 O
C 44 45 1311 1312 B-chronic_disease
virus 46 51 1313 1318 O
indicating 52 62 1319 1329 O
acute 63 68 1330 1335 B-chronic_disease
or 69 71 1336 1338 O
chronic 72 79 1339 1346 B-chronic_disease
infection 80 89 1347 1356 I-chronic_disease

Any 0 3 1357 1360 O
serious 4 11 1361 1368 O
or 12 14 1369 1371 O
uncontrolled 15 27 1372 1384 O
medical 28 35 1385 1392 O
disorder 36 44 1393 1401 O
that 45 49 1402 1406 O
, 49 50 1406 1407 O
in 51 53 1408 1410 O
the 54 57 1411 1414 O
opinion 58 65 1415 1422 O
of 66 68 1423 1425 O
the 69 72 1426 1429 O
investigator 73 85 1430 1442 O
, 85 86 1442 1443 O
may 87 90 1444 1447 O
increase 91 99 1448 1456 O
the 100 103 1457 1460 O
risk 104 108 1461 1465 O
associated 109 119 1466 1476 O
with 120 124 1477 1481 O
study 125 130 1482 1487 O
participation 131 144 1488 1501 O
or 145 147 1502 1504 O
study 148 153 1505 1510 B-treatment
drug 154 158 1511 1515 I-treatment
administration 159 173 1516 1530 O
, 173 174 1530 1531 O
impair 175 181 1532 1538 O
the 182 185 1539 1542 O
ability 186 193 1543 1550 O
of 194 196 1551 1553 O
the 197 200 1554 1557 O
subject 201 208 1558 1565 O
to 209 211 1566 1568 O
receive 212 219 1569 1576 O
protocol 220 228 1577 1585 B-treatment
therapy 229 236 1586 1593 I-treatment
, 236 237 1593 1594 O
or 238 240 1595 1597 O
interfere 241 250 1598 1607 O
with 251 255 1608 1612 O
the 256 259 1613 1616 O
interpretation 260 274 1617 1631 O
of 275 277 1632 1634 O
study 278 283 1635 1640 O
results 284 291 1641 1648 O

Aspartate 0 9 1649 1658 B-clinical_variable
aminotransferase 10 26 1659 1675 I-clinical_variable
( 27 28 1676 1677 I-clinical_variable
AST 28 31 1677 1680 I-clinical_variable
) 31 32 1680 1681 I-clinical_variable
and 33 36 1682 1685 O
alanine 37 44 1686 1693 B-clinical_variable
aminotransferase 45 61 1694 1710 I-clinical_variable
( 62 63 1711 1712 I-clinical_variable
ALT 63 66 1712 1715 I-clinical_variable
) 66 67 1715 1716 I-clinical_variable
= 68 69 1717 1718 O
< 69 70 1718 1719 O
3.0 71 74 1720 1723 B-upper_bound
x 75 76 1724 1725 I-upper_bound
upper 77 82 1726 1731 I-upper_bound
limit 83 88 1732 1737 I-upper_bound
of 89 91 1738 1740 I-upper_bound
normal 92 98 1741 1747 I-upper_bound
( 99 100 1748 1749 I-upper_bound
ULN 100 103 1749 1752 I-upper_bound
) 103 104 1752 1753 I-upper_bound
(= 105 107 1754 1756 O
< 107 108 1756 1757 O
5 109 110 1758 1759 B-upper_bound
x 111 112 1760 1761 I-upper_bound
ULN 113 116 1762 1765 I-upper_bound
for 117 120 1766 1769 O
HCC 121 124 1770 1773 B-cancer
) 124 125 1773 1774 O
( 126 127 1775 1776 O
within 127 133 1776 1782 O
28 134 136 1783 1785 B-upper_bound
days 137 141 1786 1790 I-upper_bound
of 142 144 1791 1793 O
first 145 150 1794 1799 B-treatment
study 151 156 1800 1805 I-treatment
treatment 157 166 1806 1815 I-treatment
) 166 167 1815 1816 O

Brain 0 5 1817 1822 B-cancer
metastases 6 16 1823 1833 I-cancer
, 16 17 1833 1834 O
leptomeningeal 18 32 1835 1849 B-cancer
disease 33 40 1850 1857 I-cancer
or 41 43 1858 1860 O
bone 44 48 1861 1865 B-cancer
metastases 49 59 1866 1876 I-cancer

Cardiovascular 0 14 1877 1891 B-chronic_disease
disease 15 22 1892 1899 I-chronic_disease
- 22 23 1899 1900 O
related 23 30 1900 1907 O
requirement 31 42 1908 1919 O
for 43 46 1920 1923 O
daily 47 52 1924 1929 O
supplemental 53 65 1930 1942 O
oxygen 66 72 1943 1949 O

Corrected 0 9 1950 1959 B-clinical_variable
QT 10 12 1960 1962 I-clinical_variable
interval 13 21 1963 1971 I-clinical_variable
( 22 23 1972 1973 I-clinical_variable
QTc 23 26 1973 1976 I-clinical_variable
) 26 27 1976 1977 I-clinical_variable
prolongation 28 40 1978 1990 I-clinical_variable
> 41 42 1991 1992 O
480 43 46 1993 1996 B-lower_bound
msec 47 51 1997 2001 I-lower_bound

Creatinine 0 10 2002 2012 B-clinical_variable
= 11 12 2013 2014 O
< 12 13 2014 2015 O
1.5 14 17 2016 2019 B-upper_bound
x 18 19 2020 2021 I-upper_bound
ULN 20 23 2022 2025 I-upper_bound
OR 24 26 2026 2028 O
calculated 27 37 2029 2039 B-clinical_variable
creatinine 38 48 2040 2050 I-clinical_variable
clearance 49 58 2051 2060 I-clinical_variable
> 59 60 2061 2062 O
= 60 61 2062 2063 O
40 62 64 2064 2066 B-lower_bound
mL 65 67 2067 2069 I-lower_bound
/ 67 68 2069 2070 I-lower_bound
min 68 71 2070 2073 I-lower_bound
OR 72 74 2074 2076 O
24 75 77 2077 2079 O
- 77 78 2079 2080 O
hour 78 82 2080 2084 O
urine 83 88 2085 2090 O
creatinine 89 99 2091 2101 O
clearance 100 109 2102 2111 O
> 110 111 2112 2113 O
= 111 112 2113 2114 O
50 113 115 2115 2117 B-lower_bound
mL 116 118 2118 2120 I-lower_bound
/ 118 119 2120 2121 I-lower_bound
min 119 122 2121 2124 I-lower_bound
( 123 124 2125 2126 O
within 124 130 2126 2132 O
28 131 133 2133 2135 B-upper_bound
days 134 138 2136 2140 I-upper_bound
of 139 141 2141 2143 O
first 142 147 2144 2149 O
study 148 153 2150 2155 B-treatment
treatment 154 163 2156 2165 I-treatment
) 163 164 2165 2166 O

Current 0 7 2167 2174 O
use 8 11 2175 2178 O
of 12 14 2179 2181 O
anticoagulants 15 29 2182 2196 B-treatment
( 30 31 2197 2198 O
warfarin 31 39 2198 2206 B-treatment
, 39 40 2206 2207 O
heparin 41 48 2208 2215 B-treatment
, 48 49 2215 2216 O
direct 50 56 2217 2223 B-treatment
thrombin 57 65 2224 2232 I-treatment
inhibitors 66 76 2233 2243 I-treatment
) 76 77 2243 2244 O
at 78 80 2245 2247 O
therapeutic 81 92 2248 2259 O
levels 93 99 2260 2266 O

Currently 0 9 2267 2276 O
receiving 10 19 2277 2286 O
cancer 20 26 2287 2293 B-treatment
therapy 27 34 2294 2301 I-treatment
( 35 36 2302 2303 O
chemotherapy 36 48 2303 2315 B-treatment
, 48 49 2315 2316 O
radiation 50 59 2317 2326 B-treatment
therapy 60 67 2327 2334 I-treatment
, 67 68 2334 2335 O
immunotherapy 69 82 2336 2349 B-treatment
, 82 83 2349 2350 O
or 84 86 2351 2353 O
biologic 87 95 2354 2362 B-treatment
therapy 96 103 2363 2370 I-treatment
) 103 104 2370 2371 O
or 105 107 2372 2374 O
investigational 108 123 2375 2390 B-treatment
anti 124 128 2391 2395 I-treatment
- 128 129 2395 2396 I-treatment
cancer 129 135 2396 2402 I-treatment
drug 136 140 2403 2407 I-treatment

Eastern 0 7 2408 2415 B-clinical_variable
Cooperative 8 19 2416 2427 I-clinical_variable
Oncology 20 28 2428 2436 I-clinical_variable
Group 29 34 2437 2442 I-clinical_variable
( 35 36 2443 2444 I-clinical_variable
ECOG 36 40 2444 2448 I-clinical_variable
) 40 41 2448 2449 I-clinical_variable
performance 42 53 2450 2461 I-clinical_variable
status 54 60 2462 2468 I-clinical_variable
0 61 62 2469 2470 B-lower_bound
- 62 63 2470 2471 O
1 63 64 2471 2472 B-upper_bound

Evidence 0 8 2473 2481 O
of 9 11 2482 2484 O
active 12 18 2485 2491 B-chronic_disease
infection 19 28 2492 2501 I-chronic_disease
that 29 33 2502 2506 O
requires 34 42 2507 2515 O
systemic 43 51 2516 2524 B-treatment
antibacterial 52 65 2525 2538 I-treatment
, 65 66 2538 2539 I-treatment
antiviral 67 76 2540 2549 I-treatment
, 76 77 2549 2550 I-treatment
or 78 80 2551 2553 I-treatment
antifungal 81 91 2554 2564 I-treatment
therapy 92 99 2565 2572 I-treatment
7 100 101 2573 2574 B-upper_bound
days 102 106 2575 2579 I-upper_bound
prior 107 112 2580 2585 I-upper_bound
to 113 115 2586 2588 O
initiation 116 126 2589 2599 O
of 127 129 2600 2602 O
study 130 135 2603 2608 B-treatment
drug 136 140 2609 2613 I-treatment
therapy 141 148 2614 2621 I-treatment

For 0 3 2622 2625 O
Arm 4 7 2626 2629 O
C 8 9 2630 2631 O
: 9 10 2631 2632 O
Cardiac 11 18 2633 2640 O
assessment 19 29 2641 2651 O
at 30 32 2652 2654 O
baseline 33 41 2655 2663 O
by 42 44 2664 2666 O
trans- 45 51 2667 2673 B-clinical_variable
thoracic 52 60 2674 2682 I-clinical_variable
echocardiogram 61 75 2683 2697 I-clinical_variable
( 76 77 2698 2699 I-clinical_variable
TTE 77 80 2699 2702 I-clinical_variable
) 80 81 2702 2703 I-clinical_variable
with 82 86 2704 2708 O
LVEF 87 91 2709 2713 B-clinical_variable
50 92 94 2714 2716 O
% 94 95 2716 2717 O

Hemoglobin 0 10 2718 2728 B-clinical_variable
> 11 12 2729 2730 O
= 12 13 2730 2731 O
8.5 14 17 2732 2735 B-lower_bound
g 18 19 2736 2737 I-lower_bound
/ 19 20 2737 2738 I-lower_bound
dL 20 22 2738 2740 I-lower_bound
( 23 24 2741 2742 O
within 24 30 2742 2748 O
28 31 33 2749 2751 B-upper_bound
days 34 38 2752 2756 I-upper_bound
of 39 41 2757 2759 O
first 42 47 2760 2765 O
study 48 53 2766 2771 O
treatment 54 63 2772 2781 B-treatment
) 63 64 2781 2782 O

History 0 7 2783 2790 O
of 8 10 2791 2793 O
other 11 16 2794 2799 O
clinically 17 27 2800 2810 O
significant 28 39 2811 2822 O
cardiovascular 40 54 2823 2837 B-chronic_disease
disease 55 62 2838 2845 I-chronic_disease
( 63 64 2846 2847 O
i.e. 64 68 2847 2851 O
, 68 69 2851 2852 O
cardiomyopathy 70 84 2853 2867 B-chronic_disease
, 84 85 2867 2868 O
congestive 86 96 2869 2879 B-chronic_disease
heart 97 102 2880 2885 I-chronic_disease
failure 103 110 2886 2893 I-chronic_disease
with 111 115 2894 2898 O
New 116 119 2899 2902 O
York 120 124 2903 2907 O
Heart 125 130 2908 2913 O
Association 131 142 2914 2925 O
[ 143 144 2926 2927 O
NYHA 144 148 2927 2931 O
] 148 149 2931 2932 O
functional 150 160 2933 2943 O
classification 161 175 2944 2958 O
III 176 179 2959 2962 B-lower_bound
- 179 180 2962 2963 O
IV 180 182 2963 2965 B-upper_bound
, 182 183 2965 2966 O
pericarditis 184 196 2967 2979 B-chronic_disease
, 196 197 2979 2980 O
significant 198 209 2981 2992 O
pericardial 210 221 2993 3004 O
effusion 222 230 3005 3013 I-chronic_disease
, 230 231 3013 3014 O
significant 232 243 3015 3026 O
coronary 244 252 3027 3035 O
stent 253 258 3036 3041 O
occlusion 259 268 3042 3051 O
, 268 269 3051 3052 O
deep 270 274 3053 3057 B-chronic_disease
venous 275 281 3058 3064 I-chronic_disease
thrombosis 282 292 3065 3075 I-chronic_disease
, 292 293 3075 3076 O
etc 294 297 3077 3080 O
) 298 299 3081 3082 O

History 0 7 3083 3090 O
of 8 10 3091 3093 O
severe 11 17 3094 3100 O
hypersensitivity 18 34 3101 3117 O
reaction 35 43 3118 3126 O
to 44 46 3127 3129 O
any 47 50 3130 3133 O
monoclonal 51 61 3134 3144 B-allergy_name
antibody 62 70 3145 3153 I-allergy_name

History 0 7 3154 3161 O
of 8 10 3162 3164 O
two 11 14 3165 3168 B-lower_bound
or 15 17 3169 3171 O
more 18 22 3172 3176 O
MIs 23 26 3177 3180 O
OR 27 29 3181 3183 O
two 30 33 3184 3187 O
or 34 36 3188 3190 O
more 37 41 3191 3195 O
coronary 42 50 3196 3204 B-treatment
revascularization 51 68 3205 3222 I-treatment
procedures 69 79 3223 3233 I-treatment

Known 0 5 3234 3239 O
history 6 13 3240 3247 O
of 14 16 3248 3250 O
testing 17 24 3251 3258 O
positive 25 33 3259 3267 O
for 34 37 3268 3271 O
human 38 43 3272 3277 B-chronic_disease
immunodeficiency 44 60 3278 3294 I-chronic_disease
virus 61 66 3295 3300 I-chronic_disease
or 67 69 3301 3303 O
known 70 75 3304 3309 O
acquired 76 84 3310 3318 B-chronic_disease
immunodeficiency 85 101 3319 3335 I-chronic_disease
syndrome 102 110 3336 3344 I-chronic_disease

Left 0 4 3345 3349 B-clinical_variable
ventricular 5 16 3350 3361 I-clinical_variable
ejection 17 25 3362 3370 I-clinical_variable
fraction 26 34 3371 3379 I-clinical_variable
( 35 36 3380 3381 I-clinical_variable
LVEF 36 40 3381 3385 I-clinical_variable
) 40 41 3385 3386 I-clinical_variable
> 42 43 3387 3388 O
= 43 44 3388 3389 O
50 45 47 3390 3392 B-lower_bound
% 47 48 3392 3393 I-lower_bound
by 49 51 3394 3396 O
transthoracic 52 65 3397 3410 B-treatment
echocardiography 66 82 3411 3427 I-treatment
( 83 84 3428 3429 I-treatment
TTE 84 87 3429 3432 I-treatment
) 87 88 3432 3433 I-treatment
( 89 90 3434 3435 O
preferred 90 99 3435 3444 O
) 99 100 3444 3445 O
or 101 103 3446 3448 O
multigated 104 114 3449 3459 B-treatment
acquisition 115 126 3460 3471 I-treatment
( 127 128 3472 3473 I-treatment
MUGA 128 132 3473 3477 I-treatment
) 132 133 3477 3478 I-treatment
within 134 140 3479 3485 O
6 141 142 3486 3487 B-upper_bound
months 143 149 3488 3494 I-upper_bound
from 150 154 3495 3499 O
first 155 160 3500 3505 B-treatment
study 161 166 3506 3511 I-treatment
drug 167 171 3512 3516 I-treatment
administration 172 186 3517 3531 O

Lipase 0 6 3532 3538 B-clinical_variable
< 7 8 3539 3540 O
1.5 9 12 3541 3544 B-upper_bound
X 13 14 3545 3546 I-upper_bound
ULN 15 18 3547 3550 I-upper_bound
( 19 20 3551 3552 O
within 20 26 3552 3558 O
28 27 29 3559 3561 B-upper_bound
days 30 34 3562 3566 I-upper_bound
of 35 37 3567 3569 O
first 38 43 3570 3575 O
study 44 49 3576 3581 O
treatment 50 59 3582 3591 B-treatment
) 59 60 3591 3592 O

Men 0 3 3593 3596 B-gender
who 4 7 3597 3600 O
are 8 11 3601 3604 O
sexually 12 20 3605 3613 O
active 21 27 3614 3620 O
with 28 32 3621 3625 O
WOCBP 33 38 3626 3631 O
must 39 43 3632 3636 O
use 44 47 3637 3640 B-contraception_consent
any 48 51 3641 3644 I-contraception_consent
contraceptive 52 65 3645 3658 I-contraception_consent
method 66 72 3659 3665 I-contraception_consent
with 73 77 3666 3670 O
a 78 79 3671 3672 O
failure 80 87 3673 3680 O
rate 88 92 3681 3685 O
of 93 95 3686 3688 O
< 96 97 3689 3690 O
1 98 99 3691 3692 B-upper_bound
% 99 100 3692 3693 I-upper_bound
per 101 104 3694 3697 I-upper_bound
year 105 109 3698 3702 I-upper_bound

Myocardial 0 10 3703 3713 B-chronic_disease
infarction 11 21 3714 3724 I-chronic_disease
( 22 23 3725 3726 I-chronic_disease
MI 23 25 3726 3728 I-chronic_disease
) 25 26 3728 3729 I-chronic_disease
or 27 29 3730 3732 O
stroke 30 36 3733 3739 B-chronic_disease
/ 36 37 3739 3740 O
transient 37 46 3740 3749 B-chronic_disease
ischemic 47 55 3750 3758 I-chronic_disease
attack 56 62 3759 3765 I-chronic_disease
( 63 64 3766 3767 I-chronic_disease
TIA 64 67 3767 3770 I-chronic_disease
) 67 68 3770 3771 I-chronic_disease
within 69 75 3772 3778 O
the 76 79 3779 3782 O
6 80 81 3783 3784 B-upper_bound
months 82 88 3785 3791 I-upper_bound
prior 89 94 3792 3797 I-upper_bound
to 95 97 3798 3800 O
consent 98 105 3801 3808 O

Normal 0 6 3809 3815 O
thyroid 7 14 3816 3823 O
function 15 23 3824 3832 O
( 24 25 3833 3834 O
or 25 27 3834 3836 O
stable 28 34 3837 3843 O
on 35 37 3844 3846 O
hormone 38 45 3847 3854 B-treatment
supplementation 46 61 3855 3870 I-treatment
) 61 62 3870 3871 O
0.27 63 67 3872 3876 B-lower_bound
- 68 69 3877 3878 O
10 70 72 3879 3881 B-upper_bound
X 73 74 3882 3883 I-upper_bound
10 75 77 3884 3886 I-upper_bound
^ 77 78 3886 3887 I-upper_bound
9 78 79 3887 3888 I-upper_bound
/ 79 80 3888 3889 I-upper_bound
L 80 81 3889 3890 I-upper_bound
( 82 83 3891 3892 O
within 83 89 3892 3898 O
28 90 92 3899 3901 B-upper_bound
days 93 97 3902 3906 I-upper_bound
of 98 100 3907 3909 O
first 101 106 3910 3915 O
study 107 112 3916 3921 B-treatment
treatment 113 122 3922 3931 I-treatment
) 122 123 3931 3932 O

Palliative 0 10 3933 3943 B-treatment
radiation 11 20 3944 3953 I-treatment
or 21 23 3954 3956 O
gamma 24 29 3957 3962 B-treatment

Patients 0 8 3963 3971 O
must 9 13 3972 3976 O
be 14 16 3977 3979 O
medically 17 26 3980 3989 O
fit 27 30 3990 3993 O
enough 31 37 3994 4000 O
to 38 40 4001 4003 O
undergo 41 48 4004 4011 O
surgery 49 56 4012 4019 B-treatment
as 57 59 4020 4022 O
determined 60 70 4023 4033 O
by 71 73 4034 4036 O
the 74 77 4037 4040 O
treating 78 86 4041 4049 O
medical 87 94 4050 4057 O
and 95 98 4058 4061 O
surgical 99 107 4062 4070 O
oncology 108 116 4071 4079 O
team 117 121 4080 4084 O

Patients 0 8 4085 4093 O
must 9 13 4094 4098 O
have 14 18 4099 4103 O
histologically 19 33 4104 4118 O
or 34 36 4119 4121 O
cytologically 37 50 4122 4135 O
confirmed 51 60 4136 4145 O
stage 61 66 4146 4151 B-lower_bound
IIIB 67 71 4152 4156 I-lower_bound
/ 71 72 4156 4157 O
C 72 73 4157 4158 O
or 74 76 4159 4161 O
stage 77 82 4162 4167 B-upper_bound
IV 83 85 4168 4170 I-upper_bound
oligometastatic 86 101 4171 4186 B-cancer
melanoma 102 110 4187 4195 I-cancer

Patients 0 8 4196 4204 O
who 9 12 4205 4208 O
have 13 17 4209 4213 O
been 18 22 4214 4218 O
previously 23 33 4219 4229 O
treated 34 41 4230 4237 O
in 42 44 4238 4240 O
the 45 48 4241 4244 O
adjuvant 49 57 4245 4253 B-treatment
setting 58 65 4254 4261 I-treatment
for 66 69 4262 4265 O
melanoma 70 78 4266 4274 B-cancer
will 79 83 4275 4279 O
be 84 86 4280 4282 O
eligible 87 95 4283 4291 O
for 96 99 4292 4295 O
treatment 100 109 4296 4305 B-treatment
after 110 115 4306 4311 O
a 116 117 4312 4313 O
28 118 120 4314 4316 O
day 121 124 4317 4320 O
wash 125 129 4321 4325 O
- 129 130 4325 4326 O
out 130 133 4326 4329 O
period 134 140 4330 4336 O

Patients 0 8 4337 4345 O
will 9 13 4346 4350 O
have 14 18 4351 4355 O
at 19 21 4356 4358 O
least 22 27 4359 4364 O
one 28 31 4365 4368 B-lower_bound
melanoma 32 40 4369 4377 B-cancer
deposit 41 48 4378 4385 O
that 49 53 4386 4390 O
can 54 57 4391 4394 O
undergo 58 65 4395 4402 O
serial 66 72 4403 4409 O
biopsy 73 79 4410 4416 B-treatment
( 80 81 4417 4418 O
at 81 83 4418 4420 O
least 84 89 4421 4426 O
2 90 91 4427 4428 B-lower_bound
time 92 96 4429 4433 I-lower_bound
points 97 103 4434 4440 I-lower_bound
) 103 104 4440 4441 O
during 105 111 4442 4448 O
the 112 115 4449 4452 O
neoadjuvant 116 127 4453 4464 B-treatment
phase 128 133 4465 4470 O
of 134 136 4471 4473 O
the 137 140 4474 4477 O
protocol 141 149 4478 4486 O

Platelets 0 9 4487 4496 B-clinical_variable
> 10 11 4497 4498 O
= 11 12 4498 4499 O
100 13 16 4500 4503 B-lower_bound
X 17 18 4504 4505 I-lower_bound
10 19 21 4506 4508 I-lower_bound
^ 21 22 4508 4509 I-lower_bound
9 22 23 4509 4510 I-lower_bound
/ 23 24 4510 4511 I-lower_bound
L 24 25 4511 4512 I-lower_bound
( 26 27 4513 4514 O
> 27 28 4514 4515 O
= 28 29 4515 4516 O
60 30 32 4517 4519 B-lower_bound
for 33 36 4520 4523 O
hepatocellular 37 51 4524 4538 B-clinical_variable
carcinoma 52 61 4539 4548 I-clinical_variable
[ 62 63 4549 4550 I-clinical_variable
HCC 63 66 4550 4553 I-clinical_variable
] 66 67 4553 4554 I-clinical_variable
) 67 68 4554 4555 O
( 69 70 4556 4557 O
within 70 76 4557 4563 O
28 77 79 4564 4566 B-upper_bound
days 80 84 4567 4571 I-upper_bound
of 85 87 4572 4574 O
first 88 93 4575 4580 O
study 94 99 4581 4586 B-treatment
treatment 100 109 4587 4596 I-treatment
) 109 110 4596 4597 O

Pregnant 0 8 4598 4606 B-pregnancy
or 9 11 4607 4609 O
lactating 12 21 4610 4619 O
female 22 28 4620 4626 B-gender

Prior 0 5 4627 4632 O
malignancy 6 16 4633 4643 B-cancer
active 17 23 4644 4650 O
within 24 30 4651 4657 O
the 31 34 4658 4661 O
previous 35 43 4662 4670 B-upper_bound
3 44 45 4671 4672 I-upper_bound
years 46 51 4673 4678 I-upper_bound
except 52 58 4679 4685 O
for 59 62 4686 4689 O
patient 63 70 4690 4697 O
's 70 72 4697 4699 O
prior 73 78 4700 4705 O
diagnosis 79 88 4706 4715 O
of 89 91 4716 4718 O
melanoma 92 100 4719 4727 B-cancer
and 101 104 4728 4731 O
locally 105 112 4732 4739 O
curable 113 120 4740 4747 O
cancers 121 128 4748 4755 B-cancer
that 129 133 4756 4760 O
have 134 138 4761 4765 O
been 139 143 4766 4770 O
apparently 144 154 4771 4781 O
cured 155 160 4782 4787 O
, 160 161 4787 4788 O
such 162 166 4789 4793 O
as 167 169 4794 4796 O
basal 170 175 4797 4802 B-cancer
or 176 178 4803 4805 O
squamous 179 187 4806 4814 B-cancer
cell 188 192 4815 4819 I-cancer
skin 193 197 4820 4824 I-cancer
cancer 198 204 4825 4831 I-cancer
, 204 205 4831 4832 O
superficial 206 217 4833 4844 B-cancer
bladder 218 225 4845 4852 I-cancer
cancer 226 232 4853 4859 I-cancer
, 232 233 4859 4860 O
or 234 236 4861 4863 O
carcinoma 237 246 4864 4873 B-cancer
in 247 249 4874 4876 I-cancer
situ 250 254 4877 4881 I-cancer
of 255 257 4882 4884 I-cancer
the 258 261 4885 4888 I-cancer
prostate 262 270 4889 4897 I-cancer
, 270 271 4897 4898 O
cervix 272 278 4899 4905 B-cancer
, 278 279 4905 4906 O
or 280 282 4907 4909 O
breast 283 289 4910 4916 B-cancer
with 290 294 4917 4921 O
local 295 300 4922 4927 O
control 301 308 4928 4935 O
measures 309 317 4936 4944 O
( 318 319 4945 4946 O
surgery 319 326 4946 4953 B-treatment
, 326 327 4953 4954 O
radiation 328 337 4955 4964 B-treatment
) 337 338 4964 4965 O

Prior 0 5 4966 4971 B-treatment
treatment 6 15 4972 4981 I-treatment
with 16 20 4982 4986 I-treatment
an 21 23 4987 4989 I-treatment
anti 24 28 4990 4994 I-treatment
- 28 29 4994 4995 I-treatment
PD-1 29 33 4995 4999 I-treatment
, 33 34 4999 5000 O
anti 35 39 5001 5005 B-treatment
- 39 40 5005 5006 I-treatment
PD 40 42 5006 5008 I-treatment
- 42 43 5008 5009 I-treatment
L1 43 45 5009 5011 I-treatment
, 45 46 5011 5012 O
anti 47 51 5013 5017 B-treatment
- 51 52 5017 5018 I-treatment
LAG-3 52 57 5018 5023 I-treatment
, 57 58 5023 5024 O
or 59 61 5025 5027 O
anti 62 66 5028 5032 B-treatment
- 66 67 5032 5033 I-treatment
CTLA-4 67 73 5033 5039 I-treatment
antibody 74 82 5040 5048 I-treatment

Prothrombin 0 11 5049 5060 B-clinical_variable
time 12 16 5061 5065 I-clinical_variable
( 17 18 5066 5067 I-clinical_variable
PT)/international 18 35 5067 5084 I-clinical_variable
normalized 36 46 5085 5095 I-clinical_variable
ratio 47 52 5096 5101 I-clinical_variable
( 53 54 5102 5103 I-clinical_variable
INR 54 57 5103 5106 I-clinical_variable
) 57 58 5106 5107 I-clinical_variable
and 59 62 5108 5111 O
partial 63 70 5112 5119 B-clinical_variable
thromboplastin 71 85 5120 5134 I-clinical_variable
time 86 90 5135 5139 I-clinical_variable
( 91 92 5140 5141 I-clinical_variable
PTT 92 95 5141 5144 I-clinical_variable
) 95 96 5144 5145 I-clinical_variable
= 97 98 5146 5147 O
< 98 99 5147 5148 O
1.5 100 103 5149 5152 B-upper_bound
X 104 105 5153 5154 I-upper_bound
upper 106 111 5155 5160 I-upper_bound
limit 112 117 5161 5166 I-upper_bound
of 118 120 5167 5169 I-upper_bound
normal 121 127 5170 5176 I-upper_bound
( 128 129 5177 5178 I-upper_bound
ULN 129 132 5178 5181 I-upper_bound
) 132 133 5181 5182 I-upper_bound
( 134 135 5183 5184 O
within 135 141 5184 5190 O
28 142 144 5191 5193 B-upper_bound
days 145 149 5194 5198 I-upper_bound
of 150 152 5199 5201 O
first 153 158 5202 5207 O
study 159 164 5208 5213 O
treatment 165 174 5214 5223 B-treatment
) 174 175 5223 5224 O

Subjects 0 8 5225 5233 O
who 9 12 5234 5237 O
are 13 16 5238 5241 O
compulsorily 17 29 5242 5254 B-treatment
detained 30 38 5255 5263 I-treatment
for 39 42 5264 5267 O
treatment 43 52 5268 5277 B-treatment
of 53 55 5278 5280 O
either 56 62 5281 5287 O
a 63 64 5288 5289 O
psychiatric 65 76 5290 5301 B-chronic_disease
or 77 79 5302 5304 I-chronic_disease
physical 80 88 5305 5313 I-chronic_disease
( 89 90 5314 5315 I-chronic_disease
infection 90 99 5315 5324 I-chronic_disease
disease 100 107 5325 5332 I-chronic_disease
) 107 108 5332 5333 I-chronic_disease
illness 109 116 5334 5341 I-chronic_disease

Subjects 0 8 5342 5350 O
with 9 13 5351 5355 O
a 14 15 5356 5357 O
condition 16 25 5358 5367 O
requiring 26 35 5368 5377 O
systemic 36 44 5378 5386 B-treatment
treatment 45 54 5387 5396 I-treatment
with 55 59 5397 5401 O
either 60 66 5402 5408 O
corticosteroids 67 82 5409 5424 B-treatment
( 83 84 5425 5426 O
> 84 85 5426 5427 O
10 86 88 5428 5430 B-lower_bound
mg 89 91 5431 5433 I-lower_bound
daily 92 97 5434 5439 O
prednisone 98 108 5440 5450 B-treatment
equivalents 109 120 5451 5462 O
) 120 121 5462 5463 O
or 122 124 5464 5466 O
other 125 130 5467 5472 O
immunosuppressive 131 148 5473 5490 B-treatment
medications 149 160 5491 5502 I-treatment
within 161 167 5503 5509 O
14 168 170 5510 5512 B-upper_bound
days 171 175 5513 5517 I-upper_bound
of 176 178 5518 5520 O
study 179 184 5521 5526 B-treatment
drug 185 189 5527 5531 I-treatment
administration 190 204 5532 5546 O

Subjects 0 8 5547 5555 O
with 9 13 5556 5560 O
active 14 20 5561 5567 O
, 20 21 5567 5568 O
known 22 27 5569 5574 O
or 28 30 5575 5577 O
suspected 31 40 5578 5587 O
autoimmune 41 51 5588 5598 B-chronic_disease
disease 52 59 5599 5606 I-chronic_disease

Subjects 0 8 5607 5615 O
with 9 13 5616 5620 O
history 14 21 5621 5628 O
of 22 24 5629 5631 O
life 25 29 5632 5636 O
- 29 30 5636 5637 O
threatening 30 41 5637 5648 O
toxicity 42 50 5649 5657 O
related 51 58 5658 5665 O
to 59 61 5666 5668 O
prior 62 67 5669 5674 B-treatment
immune 68 74 5675 5681 I-treatment
therapy 75 82 5682 5689 I-treatment
( 83 84 5690 5691 I-treatment
e.g. 84 88 5691 5695 I-treatment
, 88 89 5695 5696 I-treatment
anti 90 94 5697 5701 I-treatment
- 94 95 5701 5702 I-treatment
CTLA-4 95 101 5702 5708 I-treatment
or 102 104 5709 5711 I-treatment
anti 105 109 5712 5716 I-treatment
- 109 110 5716 5717 I-treatment
PD-1 110 114 5717 5721 I-treatment
/ 114 115 5721 5722 I-treatment
PD 115 117 5722 5724 I-treatment
- 117 118 5724 5725 I-treatment
L1 118 120 5725 5727 I-treatment
treatment 121 130 5728 5737 I-treatment
or 131 133 5738 5740 I-treatment
any 134 137 5741 5744 I-treatment
other 138 143 5745 5750 I-treatment
antibody 144 152 5751 5759 I-treatment
or 153 155 5760 5762 I-treatment
drug 156 160 5763 5767 I-treatment
specifically 161 173 5768 5780 I-treatment
targeting 174 183 5781 5790 I-treatment
T 184 185 5791 5792 I-treatment
- 185 186 5792 5793 I-treatment
cell 186 190 5793 5797 I-treatment
co 191 193 5798 5800 I-treatment
- 193 194 5800 5801 I-treatment
stimulation 194 205 5801 5812 I-treatment
or 206 208 5813 5815 I-treatment
immune 209 215 5816 5822 I-treatment
checkpoint 216 226 5823 5833 I-treatment
pathways 227 235 5834 5842 I-treatment
) 235 236 5842 5843 I-treatment
except 237 243 5844 5850 O
those 244 249 5851 5856 O
that 250 254 5857 5861 O
are 255 258 5862 5865 O
unlikely 259 267 5866 5874 O
to 268 270 5875 5877 O
re 271 273 5878 5880 O
- 273 274 5880 5881 O
occur 274 279 5881 5886 O
with 280 284 5887 5891 O
standard 285 293 5892 5900 O
countermeasures 294 309 5901 5916 O
( 310 311 5917 5918 O
e.g. 311 315 5918 5922 O
, 315 316 5922 5923 O
hormone 317 324 5924 5931 B-treatment
replacement 325 336 5932 5943 I-treatment
after 337 342 5944 5949 O
endocrinopathy 343 357 5950 5964 B-chronic_disease
) 357 358 5964 5965 O

Subjects 0 8 5966 5974 O
with 9 13 5975 5979 O
history 14 21 5980 5987 O
of 22 24 5988 5990 O
myocarditis 25 36 5991 6002 B-chronic_disease
, 36 37 6002 6003 O
regardless 38 48 6004 6014 O
of 49 51 6015 6017 O
etiology 52 60 6018 6026 O

Total 0 5 6027 6032 B-clinical_variable
bilirubin 6 15 6033 6042 I-clinical_variable
= 16 17 6043 6044 O
< 17 18 6044 6045 O
1.5 19 22 6046 6049 B-upper_bound
X 23 24 6050 6051 I-upper_bound
ULN 25 28 6052 6055 I-upper_bound
( 29 30 6056 6057 O
except 30 36 6057 6063 O
subjects 37 45 6064 6072 O
with 46 50 6073 6077 O
Gilbert 51 58 6078 6085 B-chronic_disease
's 58 60 6085 6087 I-chronic_disease
syndrome 61 69 6088 6096 I-chronic_disease
who 70 73 6097 6100 O
must 74 78 6101 6105 O
have 79 83 6106 6110 O
normal 84 90 6111 6117 O
direct 91 97 6118 6124 O
bilirubin 98 107 6125 6134 O
) 107 108 6134 6135 O
[ 109 110 6136 6137 O
3 110 111 6137 6138 B-upper_bound
mg 112 114 6139 6141 I-upper_bound
/ 114 115 6141 6142 I-upper_bound
dL 115 117 6142 6144 I-upper_bound
for 118 121 6145 6148 O
HCC 122 125 6149 6152 B-cancer
] 125 126 6152 6153 O
( 127 128 6154 6155 O
within 128 134 6155 6161 O
28 135 137 6162 6164 B-upper_bound
days 138 142 6165 6169 I-upper_bound
of 143 145 6170 6172 O
first 146 151 6173 6178 B-treatment
study 152 157 6179 6184 I-treatment
treatment 158 167 6185 6194 I-treatment
) 167 168 6194 6195 O

Troponin 0 8 6196 6204 B-clinical_variable
T 9 10 6205 6206 I-clinical_variable
( 11 12 6207 6208 I-clinical_variable
TnT 12 15 6208 6211 I-clinical_variable
) 15 16 6211 6212 I-clinical_variable
or 17 19 6213 6215 O
I 20 21 6216 6217 B-clinical_variable
( 22 23 6218 6219 I-clinical_variable
TnI 23 26 6219 6222 I-clinical_variable
) 26 27 6222 6223 I-clinical_variable
> 28 29 6224 6225 O
2 30 31 6226 6227 B-lower_bound
x 32 33 6228 6229 I-lower_bound
institutional 34 47 6230 6243 I-lower_bound
upper 48 53 6244 6249 I-lower_bound
limit 54 59 6250 6255 I-lower_bound
of 60 62 6256 6258 I-lower_bound
normal 63 69 6259 6265 I-lower_bound
( 70 71 6266 6267 I-lower_bound
ULN 71 74 6267 6270 I-lower_bound
) 74 75 6270 6271 I-lower_bound

Uncontrolled 0 12 6272 6284 B-chronic_disease
angina 13 19 6285 6291 I-chronic_disease
within 20 26 6292 6298 O
the 27 30 6299 6302 O
3 31 32 6303 6304 B-upper_bound
months 33 39 6305 6311 I-upper_bound
prior 40 45 6312 6317 I-upper_bound
to 46 48 6318 6320 O
consent 49 56 6321 6328 O

Uncontrolled 0 12 6329 6341 O
or 13 15 6342 6344 O
significant 16 27 6345 6356 O
cardiovascular 28 42 6357 6371 B-chronic_disease
disease 43 50 6372 6379 I-chronic_disease

WOCBP 0 5 6380 6385 O
must 6 10 6386 6390 O
follow 11 17 6391 6397 B-contraception_consent
instructions 18 30 6398 6410 I-contraception_consent
for 31 34 6411 6414 I-contraception_consent
birth 35 40 6415 6420 I-contraception_consent
control 41 48 6421 6428 I-contraception_consent
when 49 53 6429 6433 O
the 54 57 6434 6437 O
half 58 62 6438 6442 O
- 62 63 6442 6443 O
life 63 67 6443 6447 O
of 68 70 6448 6450 O
the 71 74 6451 6454 O
study 75 80 6455 6460 B-treatment
drug 81 85 6461 6465 I-treatment
is 86 88 6466 6468 O
> 89 90 6469 6470 O
24 91 93 6471 6473 B-lower_bound
hours 94 99 6474 6479 I-lower_bound

WOCBP 0 5 6480 6485 O
must 6 10 6486 6490 O
have 11 15 6491 6495 O
a 16 17 6496 6497 O
negative 18 26 6498 6506 B-pregnancy
serum 27 32 6507 6512 I-pregnancy
or 33 35 6513 6515 I-pregnancy
urine 36 41 6516 6521 I-pregnancy
pregnancy 42 51 6522 6531 I-pregnancy
test 52 56 6532 6536 O
( 57 58 6537 6538 O
minimum 58 65 6538 6545 O
sensitivity 66 77 6546 6557 B-clinical_variable
25 78 80 6558 6560 B-lower_bound
IU 81 83 6561 6563 I-lower_bound
/ 83 84 6563 6564 I-lower_bound
L 84 85 6564 6565 I-lower_bound
or 86 88 6566 6568 O
equivalent 89 99 6569 6579 O
units 100 105 6580 6585 O
of 106 108 6586 6588 O
human 109 114 6589 6594 O
chorionic 115 124 6595 6604 O
gonadotropin 125 137 6605 6617 O
[ 138 139 6618 6619 O
HCG 139 142 6619 6622 O
] 142 143 6622 6623 O
) 143 144 6623 6624 O
within 145 151 6625 6631 O
24 152 154 6632 6634 B-upper_bound
hours 155 160 6635 6640 I-upper_bound
prior 161 166 6641 6646 I-upper_bound
to 167 169 6647 6649 O
the 170 173 6650 6653 O
start 174 179 6654 6659 O
of 180 182 6660 6662 O
investigational 183 198 6663 6678 B-treatment
product 199 206 6679 6686 I-treatment

WOCBP 0 5 6687 6692 O
should 6 12 6693 6699 O
use 13 16 6700 6703 O
an 17 19 6704 6706 O
adequate 20 28 6707 6715 O
method 29 35 6716 6722 O
to 36 38 6723 6725 O
avoid 39 44 6726 6731 B-pregnancy
pregnancy 45 54 6732 6741 I-pregnancy
for 55 58 6742 6745 O
24 59 61 6746 6748 B-upper_bound
weeks 62 67 6749 6754 I-upper_bound
( 68 69 6755 6756 O
30 69 71 6756 6758 O
days 72 76 6759 6763 O
plus 77 81 6764 6768 O
the 82 85 6769 6772 O
time 86 90 6773 6777 O
required 91 99 6778 6786 O
for 100 103 6787 6790 O
study 104 109 6791 6796 B-treatment
drug 110 114 6797 6801 I-treatment
to 115 117 6802 6804 O
undergo 118 125 6805 6812 O
5 126 127 6813 6814 O
half 128 132 6815 6819 O
- 132 133 6819 6820 O
lives 133 138 6820 6825 O
) 138 139 6825 6826 O
after 140 145 6827 6832 O
the 146 149 6833 6836 O
last 150 154 6837 6841 O
dose 155 159 6842 6846 O
of 160 162 6847 6849 O
study 163 168 6850 6855 O
drug 169 173 6856 6860 O

White 0 5 6861 6866 B-clinical_variable
blood 6 11 6867 6872 I-clinical_variable
cells 12 17 6873 6878 I-clinical_variable
( 18 19 6879 6880 I-clinical_variable
WBC 19 22 6880 6883 I-clinical_variable
) 22 23 6883 6884 I-clinical_variable
> 24 25 6885 6886 O
= 25 26 6886 6887 O
2.0 27 30 6888 6891 B-lower_bound
X 31 32 6892 6893 I-lower_bound
10 33 35 6894 6896 I-lower_bound
^ 35 36 6896 6897 I-lower_bound
9 36 37 6897 6898 I-lower_bound
/ 37 38 6898 6899 I-lower_bound
L 38 39 6899 6900 I-lower_bound
( 40 41 6901 6902 O
within 41 47 6902 6908 O
28 48 50 6909 6911 B-upper_bound
days 51 55 6912 6916 I-upper_bound
of 56 58 6917 6919 O
first 59 64 6920 6925 O
study 65 70 6926 6931 O
treatment 71 80 6932 6941 B-treatment
) 80 81 6941 6942 O

Within 0 6 6943 6949 O
2 7 8 6950 6951 B-upper_bound
weeks 9 14 6952 6957 I-upper_bound
prior 15 20 6958 6963 I-upper_bound
to 21 23 6964 6966 O
time 24 28 6967 6971 O
of 29 31 6972 6974 O
study 32 37 6975 6980 O
treatment 38 47 6981 6990 B-treatment

Within 0 6 6991 6997 O
4 7 8 6998 6999 B-upper_bound
weeks 9 14 7000 7005 I-upper_bound
prior 15 20 7006 7011 I-upper_bound
to 21 23 7012 7014 O
study 24 29 7015 7020 B-treatment
drug 30 34 7021 7025 I-treatment
administration 35 49 7026 7040 O

Women 0 5 7041 7046 B-gender
are 6 9 7047 7050 O
eligible 10 18 7051 7059 O
to 19 21 7060 7062 O
participate 22 33 7063 7074 O

Women 0 5 7075 7080 B-gender
must 6 10 7081 7085 O
not 11 14 7086 7089 O
be 15 17 7090 7092 O
breastfeeding 18 31 7093 7106 O

contraception 0 13 7107 7120 O
should 14 20 7121 7127 O
be 21 23 7128 7130 O
continued 24 33 7131 7140 O
for 34 37 7141 7144 O
a 38 39 7145 7146 O
period 40 46 7147 7153 O
of 47 49 7154 7156 O
30 50 52 7157 7159 B-upper_bound
days 53 57 7160 7164 I-upper_bound
plus 58 62 7165 7169 O
the 63 66 7170 7173 O
time 67 71 7174 7178 O
required 72 80 7179 7187 O
for 81 84 7188 7191 O
the 85 88 7192 7195 O
study 89 94 7196 7201 O
drug 95 99 7202 7206 O
to 100 102 7207 7209 O
undergo 103 110 7210 7217 O
5 111 112 7218 7219 B-upper_bound
half 113 117 7220 7224 O
- 117 118 7224 7225 O
lives 118 123 7225 7230 O

females 0 7 7231 7238 B-gender
on 8 10 7239 7241 O
hormone 11 18 7242 7249 B-treatment
replacement 19 30 7250 7261 I-treatment
therapy 31 38 7262 7269 I-treatment
( 39 40 7270 7271 I-treatment
HRT 40 43 7271 7274 I-treatment
) 43 44 7274 7275 I-treatment
and 45 48 7276 7279 O
whose 49 54 7280 7285 O
menopausal 55 65 7286 7296 O
status 66 72 7297 7303 O
is 73 75 7304 7306 O
in 76 78 7307 7309 O
doubt 79 84 7310 7315 O
will 85 89 7316 7320 O
be 90 92 7321 7323 O
required 93 101 7324 7332 O
to 102 104 7333 7335 O
use 105 108 7336 7339 B-contraception_consent
one 109 112 7340 7343 I-contraception_consent
of 113 115 7344 7346 I-contraception_consent
the 116 119 7347 7350 I-contraception_consent
contraception 120 133 7351 7364 I-contraception_consent
methods 134 141 7365 7372 I-contraception_consent
if 142 144 7373 7375 O
they 145 149 7376 7380 O
wish 150 154 7381 7385 O
to 155 157 7386 7388 O
continue 158 166 7389 7397 O
their 167 172 7398 7403 O
HRT 173 176 7404 7407 O
during 177 183 7408 7414 O
the 184 187 7415 7418 O
study 188 193 7419 7424 O
; 193 194 7424 7425 O
otherwise 195 204 7426 7435 O
, 204 205 7435 7436 O
they 206 210 7437 7441 O
must 211 215 7442 7446 O
discontinue 216 227 7447 7458 O
HRT 228 231 7459 7462 O
to 232 234 7463 7465 O
allow 235 240 7466 7471 O
confirmation 241 253 7472 7484 O
of 254 256 7485 7487 O
post 257 261 7488 7492 O
- 261 262 7492 7493 O
menopausal 262 272 7493 7503 O
status 273 279 7504 7510 O
prior 280 285 7511 7516 O
to 286 288 7517 7519 O
study 289 294 7520 7525 O
enrollment 295 305 7526 7536 O

following 0 9 7537 7546 O
confirmation 10 22 7547 7559 O
of 23 25 7560 7562 O
their 26 31 7563 7568 O
post 32 36 7569 7573 O
- 36 37 7573 7574 O
menopausal 37 47 7574 7584 O
status 48 54 7585 7591 O
, 54 55 7591 7592 O
they 56 60 7593 7597 O
can 61 64 7598 7601 O
resume 65 71 7602 7608 O
use 72 75 7609 7612 O
of 76 78 7613 7615 O
HRT 79 82 7616 7619 B-treatment
during 83 89 7620 7626 O
the 90 93 7627 7630 O
study 94 99 7631 7636 O
without 100 107 7637 7644 O
use 108 111 7645 7648 O
of 112 114 7649 7651 O
a 115 116 7652 7653 O
contraceptive 117 130 7654 7667 O
method 131 137 7668 7674 O

for 0 3 7675 7678 O
PD 4 6 7679 7681 O
- 6 7 7681 7682 O
L1 7 9 7682 7684 O
testing 10 17 7685 7692 O
, 17 18 7692 7693 O
the 19 22 7694 7697 O
biopsy 23 29 7698 7704 O
should 30 36 7705 7711 O
contain 37 44 7712 7719 O
sufficient 45 55 7720 7730 O
tumor 56 61 7731 7736 B-cancer
content 62 69 7737 7744 O
( 70 71 7745 7746 O
> 71 72 7746 7747 O
100 73 76 7748 7751 B-lower_bound
tumor 77 82 7752 7757 B-clinical_variable
cells/4 83 90 7758 7765 I-clinical_variable
- 90 91 7765 7766 I-clinical_variable
micron 91 97 7766 7772 I-clinical_variable
tissue 98 104 7773 7779 I-clinical_variable
section 105 112 7780 7787 I-clinical_variable
) 112 113 7787 7788 O

for 0 3 7789 7792 O
a 4 5 7793 7794 O
teratogenic 6 17 7795 7806 B-treatment
study 18 23 7807 7812 I-treatment
drug 24 28 7813 7817 I-treatment
and/or 29 35 7818 7824 O
when 36 40 7825 7829 O
there 41 46 7830 7835 O
is 47 49 7836 7838 O
insufficient 50 62 7839 7851 O
information 63 74 7852 7863 O
to 75 77 7864 7866 O
assess 78 84 7867 7873 O
teratogenicity 85 99 7874 7888 B-treatment
, 99 100 7888 7889 O
a 101 102 7890 7891 O
highly 103 109 7892 7898 O
effective 110 119 7899 7908 O
method(s 120 128 7909 7917 O
) 128 129 7917 7918 O
of 130 132 7919 7921 O
contraception 133 146 7922 7935 O
( 147 148 7936 7937 O
failure 148 155 7937 7944 B-clinical_variable
rate 156 160 7945 7949 I-clinical_variable
of 161 163 7950 7952 O
< 164 165 7953 7954 O
1 166 167 7955 7956 B-upper_bound
% 167 168 7956 7957 I-upper_bound
per 169 172 7958 7961 I-upper_bound
year 173 177 7962 7966 I-upper_bound
) 177 178 7966 7967 O
is 179 181 7968 7970 O
required 182 190 7971 7979 O

for 0 3 7980 7983 O
most 4 8 7984 7988 O
forms 9 14 7989 7994 O
of 15 17 7995 7997 O
HRT 18 21 7998 8001 B-treatment
, 21 22 8001 8002 O
at 23 25 8003 8005 O
least 26 31 8006 8011 O
2 32 33 8012 8013 B-lower_bound
- 33 34 8013 8014 O
4 34 35 8014 8015 B-upper_bound
weeks 36 41 8016 8021 I-upper_bound
will 42 46 8022 8026 O
elapse 47 53 8027 8033 O
between 54 61 8034 8041 O
the 62 65 8042 8045 O
cessation 66 75 8046 8055 O
of 76 78 8056 8058 O
therapy 79 86 8059 8066 B-treatment
and 87 90 8067 8070 O
the 91 94 8071 8074 O
blood 95 100 8075 8080 O
draw 101 105 8081 8085 O

for 0 3 8086 8089 O
patients 4 12 8090 8098 O
with 13 17 8099 8103 O
stage 18 23 8104 8109 B-cancer
IV 24 26 8110 8112 I-cancer
disease 27 34 8113 8120 I-cancer
with 35 39 8121 8125 I-cancer
distant 40 47 8126 8133 I-cancer
lymph 48 53 8134 8139 I-cancer
nodes 54 59 8140 8145 I-cancer
( 60 61 8146 8147 I-cancer
stage 61 66 8147 8152 I-cancer
M1a 67 70 8153 8156 I-cancer
) 70 71 8156 8157 I-cancer
, 71 72 8157 8158 I-cancer
a 73 74 8159 8160 O
maximum 75 82 8161 8168 O
of 83 85 8169 8171 O
three 86 91 8172 8177 O
separate 92 100 8178 8186 O
lymph 101 106 8187 8192 O
node 107 111 8193 8197 O
sites 112 117 8198 8203 O
fit 118 121 8204 8207 O
the 122 125 8208 8211 O
definition 126 136 8212 8222 O
of 137 139 8223 8225 O
oligometastatic 140 155 8226 8241 B-cancer
disease 156 163 8242 8249 I-cancer

for 0 3 8250 8253 O
patients 4 12 8254 8262 O
with 13 17 8263 8267 O
stage 18 23 8268 8273 B-cancer
IV 24 26 8274 8276 I-cancer
disease 27 34 8277 8284 I-cancer
, 34 35 8284 8285 O
site 36 40 8286 8290 O
of 41 43 8291 8293 O
tumor 44 49 8294 8299 B-cancer
biopsy 50 56 8300 8306 B-treatment
will 57 61 8307 8311 O
preferably 62 72 8312 8322 O
be 73 75 8323 8325 O
from 76 80 8326 8330 O
non 81 84 8331 8334 B-cancer
- 84 85 8334 8335 I-cancer
lymph 85 90 8335 8340 I-cancer
node 91 95 8341 8345 I-cancer
disease 96 103 8346 8353 O
site 104 108 8354 8358 O

if 0 2 8359 8361 O
a 3 4 8362 8363 O
sample 5 11 8364 8370 O
contains 12 20 8371 8379 O
insufficient 21 33 8380 8392 O
tumor 34 39 8393 8398 B-cancer
content 40 47 8399 8406 O
, 47 48 8406 8407 O
a 49 50 8408 8409 O
re 51 53 8410 8412 O
- 53 54 8412 8413 O
biopsy 54 60 8413 8419 B-treatment
will 61 65 8420 8424 O
be 66 68 8425 8427 O
required 69 77 8428 8436 O
to 78 80 8437 8439 O
obtain 81 87 8440 8446 O
a 88 89 8447 8448 O
sample 90 96 8449 8455 O
with 97 101 8456 8460 O
sufficient 102 112 8461 8471 O
tumor 113 118 8472 8477 O
content 119 126 8478 8485 O
prior 127 132 8486 8491 O
to 133 135 8492 8494 O
treatment 136 145 8495 8504 B-treatment

inhaled 0 7 8505 8512 B-treatment
or 8 10 8513 8515 O
topical 11 18 8516 8523 B-treatment
steroids 19 27 8524 8532 I-treatment
and 28 31 8533 8536 O
adrenal 32 39 8537 8544 B-treatment
replacement 40 51 8545 8556 I-treatment
doses 52 57 8557 8562 O
> 58 59 8563 8564 O
10 60 62 8565 8567 B-lower_bound
mg 63 65 8568 8570 I-lower_bound
daily 66 71 8571 8576 O
prednisone 72 82 8577 8587 B-treatment
equivalents 83 94 8588 8599 O
are 95 98 8600 8603 O
permitted 99 108 8604 8613 O
in 109 111 8614 8616 O
the 112 115 8617 8620 O
absence 116 123 8621 8628 O
of 124 126 8629 8631 O
active 127 133 8632 8638 O
autoimmune 134 144 8639 8649 B-chronic_disease
disease 145 152 8650 8657 I-chronic_disease

inhaled 0 7 8658 8665 B-treatment
or 8 10 8666 8668 O
topical 11 18 8669 8676 B-treatment
steroids 19 27 8677 8685 I-treatment
, 27 28 8685 8686 O
and 29 32 8687 8690 O
adrenal 33 40 8691 8698 B-treatment
replacement 41 52 8699 8710 I-treatment
steroid 53 60 8711 8718 I-treatment
doses 61 66 8719 8724 O
of 67 69 8725 8727 O
> 70 71 8728 8729 O
10 72 74 8730 8732 B-lower_bound
mg 75 77 8733 8735 I-lower_bound
daily 78 83 8736 8741 O
prednisone 84 94 8742 8752 B-treatment
equivalent 95 105 8753 8763 O
, 105 106 8763 8764 O
are 107 110 8765 8768 O
permitted 111 120 8769 8778 O
in 121 123 8779 8781 O
the 124 127 8782 8785 O
absence 128 135 8786 8793 O
of 136 138 8794 8796 O
active 139 145 8797 8803 O
autoimmune 146 156 8804 8814 B-chronic_disease
disease 157 164 8815 8822 I-chronic_disease

male 0 4 8823 8827 B-gender
participants 5 17 8828 8840 I-gender
must 18 22 8841 8845 O
be 23 25 8846 8848 O
willing 26 33 8849 8856 O
to 34 36 8857 8859 O
refrain 37 44 8860 8867 O
from 45 49 8868 8872 O
sperm 50 55 8873 8878 O
donation 56 64 8879 8887 O
during 65 71 8888 8894 O
this 72 76 8895 8899 O
time 77 81 8900 8904 O

men 0 3 8905 8908 B-gender
who 4 7 8909 8912 O
are 8 11 8913 8916 O
sexually 12 20 8917 8925 O
active 21 27 8926 8932 O
with 28 32 8933 8937 O
WOCBP 33 38 8938 8943 O
must 39 43 8944 8948 O
continue 44 52 8949 8957 B-contraception_consent
contraception 53 66 8958 8971 I-contraception_consent
for 67 70 8972 8975 O
33 71 73 8976 8978 B-upper_bound
weeks 74 79 8979 8984 I-upper_bound
( 80 81 8985 8986 O
90 81 83 8986 8988 O
days 84 88 8989 8993 O
plus 89 93 8994 8998 O
the 94 97 8999 9002 O
time 98 102 9003 9007 O
required 103 111 9008 9016 O
for 112 115 9017 9020 O
nivolumab 116 125 9021 9030 B-treatment
and/or 126 132 9031 9037 O
relatlimab 133 143 9038 9048 B-treatment
to 144 146 9049 9051 O
undergo 147 154 9052 9059 O
5 155 156 9060 9061 O
half 157 161 9062 9066 O
- 161 162 9066 9067 O
lives 162 167 9067 9072 O
) 167 168 9072 9073 O
after 169 174 9074 9079 O
the 175 178 9080 9083 O
last 179 183 9084 9088 O
dose 184 188 9089 9093 O
of 189 191 9094 9096 O
study 192 197 9097 9102 B-treatment
drug 198 202 9103 9107 I-treatment

men 0 3 9108 9111 B-gender
who 4 7 9112 9115 O
are 8 11 9116 9119 O
sexually 12 20 9120 9128 O
active 21 27 9129 9135 O
with 28 32 9136 9140 O
WOCBP 33 38 9141 9146 O
must 39 43 9147 9151 O
follow 44 50 9152 9158 O
instructions 51 63 9159 9171 O
for 64 67 9172 9175 O
birth 68 73 9176 9181 O
control 74 81 9182 9189 O
when 82 86 9190 9194 O
the 87 90 9195 9198 O
half 91 95 9199 9203 O
- 95 96 9203 9204 O
life 96 100 9204 9208 O
of 101 103 9209 9211 O
the 104 107 9212 9215 O
study 108 113 9216 9221 B-treatment
drug 114 118 9222 9226 I-treatment
is 119 121 9227 9229 O
> 122 123 9230 9231 O
24 124 126 9232 9234 B-lower_bound
hours 127 132 9235 9240 I-lower_bound
, 132 133 9240 9241 O
contraception 134 147 9242 9255 O
should 148 154 9256 9262 O
be 155 157 9263 9265 O
continued 158 167 9266 9275 O
for 168 171 9276 9279 O
90 172 174 9280 9282 B-upper_bound
days 175 179 9283 9287 I-upper_bound
plus 180 184 9288 9292 O
the 185 188 9293 9296 O
time 189 193 9297 9301 O
required 194 202 9302 9310 O
for 203 206 9311 9314 O
the 207 210 9315 9318 O
study 211 216 9319 9324 O
drug 217 221 9325 9329 O
to 222 224 9330 9332 O
undergo 225 232 9333 9340 O
5 233 234 9341 9342 B-upper_bound
half 235 239 9343 9347 I-upper_bound
- 239 240 9347 9348 I-upper_bound
lives 240 245 9348 9353 I-upper_bound

men 0 3 9354 9357 B-gender
who 4 7 9358 9361 O
are 8 11 9362 9365 O
sexually 12 20 9366 9374 O
active 21 27 9375 9381 O
with 28 32 9382 9386 O
women 33 38 9387 9392 B-gender
who 39 42 9393 9396 O
are 43 46 9397 9400 O
not 47 50 9401 9404 O
of 51 53 9405 9407 O
childbearing 54 66 9408 9420 O
potential 67 76 9421 9430 O
( 77 78 9431 9432 O
i.e. 78 82 9432 9436 O
, 82 83 9436 9437 O
who 84 87 9438 9441 O
are 88 91 9442 9445 O
postmenopausal 92 106 9446 9460 O
or 107 109 9461 9463 O
surgically 110 120 9464 9474 O
sterile 121 128 9475 9482 O
and 129 132 9483 9486 O
azoospermic 133 144 9487 9498 O
men 145 148 9499 9502 O
) 148 149 9502 9503 O
do 150 152 9504 9506 O
not 153 156 9507 9510 O
require 157 164 9511 9518 O
contraception 165 178 9519 9532 O

non 0 3 9533 9536 O
- 3 4 9536 9537 O
childbearing 4 16 9537 9549 O
potential 17 26 9550 9559 O
defined 27 34 9560 9567 O
as 35 37 9568 9570 O
pre 38 41 9571 9574 O
- 41 42 9574 9575 O
menopausal 42 52 9575 9585 O
females 53 60 9586 9593 B-gender
with 61 65 9594 9598 O
a 66 67 9599 9600 O
documented 68 78 9601 9611 O
tubal 79 84 9612 9617 O
ligation 85 93 9618 9626 O
or 94 96 9627 9629 O
hysterectomy 97 109 9630 9642 O

oligometastatic 0 15 9643 9658 B-cancer
melanoma 16 24 9659 9667 I-cancer
is 25 27 9668 9670 O
defined 28 35 9671 9678 O
as 36 38 9679 9681 O
three 39 44 9682 9687 B-upper_bound
or 45 47 9688 9690 O
fewer 48 53 9691 9696 O
areas 54 59 9697 9702 O
of 60 62 9703 9705 O
resectable 63 73 9706 9716 O
disease 74 81 9717 9724 O
excluding 82 91 9725 9734 O
central 92 99 9735 9742 O
nervous 100 107 9743 9750 O
system 108 114 9751 9757 O
and 115 118 9758 9761 O
bone 119 123 9762 9766 O
involvement 124 135 9767 9778 O

only 0 4 9779 9783 O
cases 5 10 9784 9789 O
where 11 16 9790 9795 O
a 17 18 9796 9797 O
complete 19 27 9798 9806 O
surgical 28 36 9807 9815 B-treatment
resection 37 46 9816 9825 I-treatment
with 47 51 9826 9830 O
tumor 52 57 9831 9836 B-cancer
- 57 58 9836 9837 O
free 58 62 9837 9841 O
margins 63 70 9842 9849 O
can 71 74 9850 9853 O
safely 75 81 9854 9860 O
be 82 84 9861 9863 O
achieved 85 93 9864 9872 O
are 94 97 9873 9876 O
defined 98 105 9877 9884 O
as 106 108 9885 9887 O
resectable 109 119 9888 9898 O

patients 0 8 9899 9907 O
must 9 13 9908 9912 O
be 14 16 9913 9915 O
willing 17 24 9916 9923 O
to 25 27 9924 9926 O
provide 28 35 9927 9934 O
tumor 36 41 9935 9940 B-cancer
samples 42 49 9941 9948 O
at 50 52 9949 9951 O
the 53 56 9952 9955 O
time 57 61 9956 9960 O
points 62 68 9961 9967 O
specified 69 78 9968 9977 O
in 79 81 9978 9980 O
the 82 85 9981 9984 O
Study 86 91 9985 9990 O
Procedure 92 101 9991 10000 O
Tables 102 108 10001 10007 O

patients 0 8 10008 10016 O
with 9 13 10017 10021 O
cutaneous 14 23 10022 10031 B-cancer
, 23 24 10031 10032 O
mucosal 25 32 10033 10040 B-cancer
, 32 33 10040 10041 O
acral 34 39 10042 10047 B-cancer
, 39 40 10047 10048 O
ocular 41 47 10049 10055 B-cancer
or 48 50 10056 10058 O
unknown 51 58 10059 10066 B-cancer
primary 59 66 10067 10074 I-cancer
melanomas 67 76 10075 10084 I-cancer
are 77 80 10085 10088 O
eligible 81 89 10089 10097 O
for 90 93 10098 10101 O
enrollment 94 104 10102 10112 O

postmenopausal 0 14 10113 10127 O
defined 15 22 10128 10135 O
as 23 25 10136 10138 O
12 26 28 10139 10141 B-upper_bound
months 29 35 10142 10148 I-upper_bound
of 36 38 10149 10151 O
spontaneous 39 50 10152 10163 O
amenorrhea 51 61 10164 10174 B-chronic_disease
( 62 63 10175 10176 O
in 63 65 10176 10178 O
questionable 66 78 10179 10191 O
cases 79 84 10192 10197 O
a 85 86 10198 10199 O
blood 87 92 10200 10205 O
sample 93 99 10206 10212 O
with 100 104 10213 10217 O
simultaneous 105 117 10218 10230 O
follicle 118 126 10231 10239 B-clinical_variable
stimulating 127 138 10240 10251 I-clinical_variable
hormone 139 146 10252 10259 I-clinical_variable
[ 147 148 10260 10261 I-clinical_variable
FSH 148 151 10261 10264 I-clinical_variable
] 151 152 10264 10265 I-clinical_variable
> 153 154 10266 10267 O
40 155 157 10268 10270 B-lower_bound
MlU 158 161 10271 10274 I-lower_bound
/ 161 162 10274 10275 I-lower_bound
mL 162 164 10275 10277 I-lower_bound
and 165 168 10278 10281 O
estradiol 169 178 10282 10291 B-clinical_variable
< 179 180 10292 10293 O
40 181 183 10294 10296 B-upper_bound
pg 184 186 10297 10299 I-upper_bound
/ 186 187 10299 10300 I-upper_bound
mL 187 189 10300 10302 I-upper_bound
[ 190 191 10303 10304 O
< 191 192 10304 10305 O
140 193 196 10306 10309 B-upper_bound
pmol 197 201 10310 10314 I-upper_bound
/ 201 202 10314 10315 I-upper_bound
L 202 203 10315 10316 I-upper_bound
] 203 204 10316 10317 I-upper_bound
is 205 207 10318 10320 O
confirmatory 208 220 10321 10333 O
) 220 221 10333 10334 O

resectable 0 10 10335 10345 O
tumors 11 17 10346 10352 B-cancer
are 18 21 10353 10356 O
defined 22 29 10357 10364 O
as 30 32 10365 10367 O
having 33 39 10368 10374 O
no 40 42 10375 10377 O
significant 43 54 10378 10389 O
vascular 55 63 10390 10398 O
, 63 64 10398 10399 O
neural 65 71 10400 10406 O
or 72 74 10407 10409 O
bony 75 79 10410 10414 O
involvement 80 91 10415 10426 O

subjects 0 8 10427 10435 O
with 9 13 10436 10440 O
TnT 14 17 10441 10444 B-clinical_variable
or 18 20 10445 10447 I-clinical_variable
TnI 21 24 10448 10451 I-clinical_variable
levels 25 31 10452 10458 I-clinical_variable
between 32 39 10459 10466 O
> 40 41 10467 10468 O
1 42 43 10469 10470 B-lower_bound
to 44 46 10471 10473 O
2 47 48 10474 10475 B-upper_bound
x 49 50 10476 10477 I-upper_bound
ULN 51 54 10478 10481 I-upper_bound
will 55 59 10482 10486 O
be 60 62 10487 10489 O
permitted 63 72 10490 10499 O
if 73 75 10500 10502 O
repeat 76 82 10503 10509 O
levels 83 89 10510 10516 O
within 90 96 10517 10523 O
24 97 99 10524 10526 B-upper_bound
hours 100 105 10527 10532 I-upper_bound
are 106 109 10533 10536 O
< 110 111 10537 10538 O
/= 111 113 10538 10540 O
1 114 115 10541 10542 B-upper_bound
x 116 117 10543 10544 I-upper_bound
ULN 118 121 10545 10548 I-upper_bound
; 121 122 10548 10549 O
if 123 125 10550 10552 O
TnT 126 129 10553 10556 O
or 130 132 10557 10559 O
TnI 133 136 10560 10563 O
levels 137 143 10564 10570 O
are 144 147 10571 10574 O
> 148 149 10575 10576 O
1 150 151 10577 10578 O
to 152 154 10579 10581 O
2 155 156 10582 10583 O
x 157 158 10584 10585 O
ULN 159 162 10586 10589 O
within 163 169 10590 10596 O
24 170 172 10597 10599 O
hours 173 178 10600 10605 O
, 178 179 10605 10606 O
the 180 183 10607 10610 O
subject 184 191 10611 10618 O
may 192 195 10619 10622 O
undergo 196 203 10623 10630 O
a 204 205 10631 10632 O
cardiac 206 213 10633 10640 O
evaluation 214 224 10641 10651 O
and 225 228 10652 10655 O
be 229 231 10656 10658 O
considered 232 242 10659 10669 O
for 243 246 10670 10673 O
treatment 247 256 10674 10683 B-treatment
, 256 257 10683 10684 O
following 258 267 10685 10694 O
a 268 269 10695 10696 O
discussion 270 280 10697 10707 O
with 281 285 10708 10712 O
the 286 289 10713 10716 O
investigator 290 302 10717 10729 O
or 303 305 10730 10732 O
designee 306 314 10733 10741 O

subjects 0 8 10742 10750 O
with 9 13 10751 10755 O
vitiligo 14 22 10756 10764 B-chronic_disease
, 22 23 10764 10765 O
type 24 28 10766 10770 B-chronic_disease
I 29 30 10771 10772 I-chronic_disease
diabetes 31 39 10773 10781 I-chronic_disease
mellitus 40 48 10782 10790 I-chronic_disease
, 48 49 10790 10791 O
residual 50 58 10792 10800 O
hypothyroidism 59 73 10801 10815 B-chronic_disease
due 74 77 10816 10819 O
to 78 80 10820 10822 O
autoimmune 81 91 10823 10833 B-chronic_disease
condition 92 101 10834 10843 I-chronic_disease
only 102 106 10844 10848 O
requiring 107 116 10849 10858 O
hormone 117 124 10859 10866 B-treatment
replacement 125 136 10867 10878 I-treatment
, 136 137 10878 10879 O
psoriasis 138 147 10880 10889 B-chronic_disease
not 148 151 10890 10893 O
requiring 152 161 10894 10903 O
systemic 162 170 10904 10912 B-treatment
treatment 171 180 10913 10922 I-treatment
, 180 181 10922 10923 O
or 182 184 10924 10926 O
conditions 185 195 10927 10937 O
not 196 199 10938 10941 O
expected 200 208 10942 10950 O
to 209 211 10951 10953 O
recur 212 217 10954 10959 O
in 218 220 10960 10962 O
the 221 224 10963 10966 O
absence 225 232 10967 10974 O
of 233 235 10975 10977 O
an 236 238 10978 10980 O
external 239 247 10981 10989 O
trigger 248 255 10990 10997 O
are 256 259 10998 11001 O
permitted 260 269 11002 11011 O
to 270 272 11012 11014 O
enroll 273 279 11015 11021 O

the 0 3 11022 11025 O
28 4 6 11026 11028 B-treatment
- 6 7 11028 11029 I-treatment
8 7 8 11029 11030 I-treatment
clone 9 14 11031 11036 I-treatment
for 15 18 11037 11040 I-treatment
PD 19 21 11041 11043 I-treatment
- 21 22 11043 11044 I-treatment
L1 22 24 11044 11046 I-treatment
testing 25 32 11047 11054 I-treatment
is 33 35 11055 11057 O
required 36 44 11058 11066 O
for 45 48 11067 11070 O
assessment 49 59 11071 11081 O
of 60 62 11082 11084 O
PD 63 65 11085 11087 O
- 65 66 11087 11088 O
L1 66 68 11088 11090 O
status 69 75 11091 11097 O

this 0 4 11098 11102 O
interval 5 13 11103 11111 O
depends 14 21 11112 11119 O
on 22 24 11120 11122 O
the 25 28 11123 11126 O
type 29 33 11127 11131 O
and 34 37 11132 11135 O
dosage 38 44 11136 11142 O
of 45 47 11143 11145 O
HRT 48 51 11146 11149 B-treatment

when 0 4 11150 11154 O
repeat 5 11 11155 11161 O
levels 12 18 11162 11168 O
within 19 25 11169 11175 O
24 26 28 11176 11178 B-upper_bound
hours 29 34 11179 11184 I-upper_bound
are 35 38 11185 11188 O
not 39 42 11189 11192 O
available 43 52 11193 11202 O
, 52 53 11202 11203 O
a 54 55 11204 11205 O
repeat 56 62 11206 11212 O
test 63 67 11213 11217 O
should 68 74 11218 11224 O
be 75 77 11225 11227 O
conducted 78 87 11228 11237 O
as 88 90 11238 11240 O
soon 91 95 11241 11245 O
as 96 98 11246 11248 O
possible 99 107 11249 11257 O

ystemic 0 7 11258 11265 B-treatment
or 8 10 11266 11268 O
topical 11 18 11269 11276 B-treatment
corticosteroids 19 34 11277 11292 I-treatment
at 35 37 11293 11295 O
immunosuppressive 38 55 11296 11313 B-chronic_disease
doses 56 61 11314 11319 O
( 62 63 11320 11321 O
> 63 64 11321 11322 O
10 65 67 11323 11325 B-lower_bound
mg 68 70 11326 11328 I-lower_bound
/ 70 71 11328 11329 I-lower_bound
day 71 74 11329 11332 I-lower_bound
of 75 77 11333 11335 O
prednisone 78 88 11336 11346 B-treatment
or 89 91 11347 11349 O
equivalent 92 102 11350 11360 O
) 102 103 11360 11361 O

